# A Study of the Effectiveness of Armodafinil to Treat Cancer-Related Fatigue in Patients With Multiple Myeloma

> **NCT01160380** · PHASE3 · COMPLETED · sponsor: **Oncotherapeutics** · enrollment: 50 (actual)

## Conditions studied

- Fatigue
- Multiple Myeloma

## Interventions

- **DRUG:** armodafinil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01160380
- **Lead sponsor:** Oncotherapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2013-06
- **Final completion:** 2014-05
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2014-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01160380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01160380, "A Study of the Effectiveness of Armodafinil to Treat Cancer-Related Fatigue in Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01160380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*